Approval of Laboratories To Conduct Official Testing; Consolidation of Regulations, 4192-4196 [2020-01114]
Download as PDF
4192
Federal Register / Vol. 85, No. 16 / Friday, January 24, 2020 / Rules and Regulations
A hard copy may also be requested in
one of the following ways:
• Via mail: karen.fullen@usda.gov
with ‘‘Request for EA’’ in the subject
line; or
• A written request: Karen Fullen,
Environmental Compliance Specialist,
Natural Resources Conservation Service,
9173 W Barnes Dr., Suite C, Boise, ID
83709.
FOR FURTHER INFORMATION CONTACT:
Jeffrey White, 202–720–1882; email:
Jeffrey.White2@usda.gov. Persons with
disabilities who require alternative
means for communication should
contact the USDA Target Center at (202)
720–2600 (voice).
SUPPLEMENTARY INFORMATION: The ACEP
interim rule was published in the
Federal Register on January 6, 2020, (85
FR 558–590) to make changes to the
ACEP policies and procedures in the
ACEP regulations in 7 CFR part 1468.
This correction is being published to
address minor errors in the preamble
portion of the ACEP interim rule. There
are no changes to the ACEP regulations
as published on January 6, 2020.
The Docket ID provided in the
ADDRESSES section in the interim rule
was incorrect as it should have matched
the number provided in the document
heading. The correct Docket ID is
NRCS–2019–0006 and is correct
throughout this document.
Additionally, in the ACEP wetland
reserve easements (ACEP–WRE) KeyChanges preamble section on ACEP–
WRE Wetland Restoration, on page 564
of the January 6, 2020, interim rule, the
definition of ‘‘wetland restoration’’ from
the previous ACEP regulation had been
included for reference. NRCS recognizes
that including the former definition may
cause confusion. The interim rule
revised the definition, and the new
definition for the term ‘‘wetland
restoration’’ can be found in § 1468.3 as
revised.
lotter on DSKBCFDHB2PROD with RULES
Request for Public Input
At the time the interim rule was
published, NRCS intended to request
comment with respect to two additional
matters.
In the discussion of § 1468.20(d)
under the preamble heading ‘‘Summary
of Changes to Subpart B, Agricultural
Land Easements (ACEP–ALE)’’, on page
565 of the interim rule, NRCS discussed
the criteria by which land can be
determined eligible and explains the
reasons why land enrolled in ACEP–
ALE cannot include forest land greater
than two-thirds of the ACEP–ALE
easement area. NRCS is requesting
public comment about whether other
NRCS conservation programs with an
VerDate Sep<11>2014
15:58 Jan 23, 2020
Jkt 250001
easement component, such as the
Healthy Forest Reserve Program or the
Regional Conservation Partnership
Program, should be used to assist in the
protection of agricultural lands on
which nonindustrial private forest is the
predominate use at levels beyond the
scope of ACEP–ALE.
Additionally, NRCS requests public
comment on recommendations to
streamline access to ACEP and input on
new or existing ranking criteria that
would assist NRCS in selecting projects
that best further ACEP purposes.
Specifically, NRCS is considering
whether there is anything that would fit
under the language ‘other related
conservation benefits’ identified in
§ 1468.22(c)(3)(iv) that would not fit
within the other criteria listed in
§ 1468.22(c)(3), in consideration of
whether the criteria of ‘other related
conservation benefits’ should be kept
(see page 580 of the interim rule). All
comments received on or before the
closing date for comments, March 20,
2020, will be considered. NRCS will
review and respond to the public
comments in the ACEP final rule.
The comment period for the ACEP
interim rule was initially scheduled to
close on March 6, 2020. This correction
extends the comment period, which will
now close on March 20, 2020. The
public comment period for the EA and
FONSI has also been extended until
March 20, 2020. In addition, the URL in
the January 6, 2020, interim rule for the
EA and FONSI was in error. There have
been no changes to either the EA or
FONSI, the correction is that the URL
was not going to the web page that
contains the EA and FONSI. A copy of
the EA and FONSI may be obtained at
https://www.nrcs.usda.gov/wps/portal/
nrcs/detailfull/national/programs/
farmbill/?cid=stelprdb1263599.
Kevin Norton,
Associate Chief, Natural Resources
Conservation Service.
Robert Stephenson,
Executive Vice President, Commodity Credit
Corporation.
[FR Doc. 2020–01066 Filed 1–22–20; 4:15 pm]
BILLING CODE 3410–16–P
PO 00000
DEPARTMENT OF AGRICULTURE
Animal and Plant Health Inspection
Service
9 CFR Parts 71, 75, 80, and 93
[Docket No. APHIS–2016–0054]
RIN 0579–AE46
Approval of Laboratories To Conduct
Official Testing; Consolidation of
Regulations
Animal and Plant Health
Inspection Service, USDA.
ACTION: Final rule.
AGENCY:
We are consolidating the
regulations governing diagnostic
laboratory approval authorities for select
animal diseases into a single regulation
and establishing a set of standard
procedures that we will use to conduct
future diagnostic laboratory approvals.
These consolidated regulations will
provide for consistent inspection
protocols, proficiency testing methods,
quality system guidelines, and
definitions and will facilitate the
approval of additional laboratories in
emergency situations. The consolidated
regulations will serve to simplify
regulatory oversight and compliance.
DATES: February 24, 2020.
FOR FURTHER INFORMATION CONTACT: Dr.
Randall L. Levings, Scientific Advisor,
Diagnostics and Biologics, VS, APHIS,
1920 Dayton Ave., Ames, IA 50010–
9602; (515) 337–7601.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Background
The regulations in 9 CFR subchapters
B, C, and D pertain to the cooperative
control and eradication of livestock or
poultry diseases (subchapter B), the
interstate transportation of animals
(including poultry) and animal products
(subchapter C), and the exportation and
importation of animals (including
poultry) and animal products
(subchapter D).
In a proposed rule 1 published in the
Federal Register on May 30, 2019 (84
FR 25013–25018, Docket No. APHIS–
2016–0054), we proposed to consolidate
the regulations governing diagnostic
laboratory approval authorities for
animal diseases covered by 9 CFR
subchapters B through D into a single
regulation and establish a set of
standard procedures that we would use
to conduct future diagnostic laboratory
1 To view the proposed rule, supporting
documents, and the comments we received, go to
https://www.regulations.gov/docket?D=APHIS2016-0054.
Frm 00002
Fmt 4700
Sfmt 4700
E:\FR\FM\24JAR1.SGM
24JAR1
lotter on DSKBCFDHB2PROD with RULES
Federal Register / Vol. 85, No. 16 / Friday, January 24, 2020 / Rules and Regulations
approvals. The consolidated regulations
are intended to provide for consistent
inspection protocols, proficiency testing
methods, quality system guidelines, and
definitions; facilitate the approval of
additional laboratories in emergency
situations; and simplify regulatory
oversight and compliance.
We solicited comments for 60 days
ending on July 29, 2019. We received
six comments by that date, from private
citizens and a State animal health
commission. All the commenters
generally supported the proposed rule.
One commenter did raise a few
questions, which are discussed below.
As part of the proposed rule, we
proposed to remove the specific
laboratory approval provisions found in
our regulations regarding equine
infectious anemia, Johne’s disease, and
contagious equine metritis. One
commenter noted that the scope of the
proposed regulations could appear to be
limited to those three diseases, but
stated they favored a more expansive
interpretation that would include all the
diseases cited in 9 CFR subchapters B,
C, and D.
The commenter’s more expansive
interpretation is correct. As stated in
proposed § 71.22(a), State, university,
and private laboratories must obtain
Animal and Plant Health Inspection
Service (APHIS) approval to conduct
official testing for those diseases
covered by subchapters B, C, and D and
must meet the requirements of § 71.22
in order to obtain and maintain that
approval.
The same commenter stated that it
should be clear that regulations also
apply to laboratories that test for other
communicable diseases of livestock or
poultry that the Secretary may
determine constitute an emergency and
pose a threat to animal health. In that
vein, the commenter also encouraged
APHIS to continue to develop
regulations for a national list of
reportable animal diseases.
As anticipated by the commenter, the
regulations will serve as the framework
for the approval of laboratories that test
for new or emerging communicable
diseases of livestock or poultry for
which tests are available should there be
a need for those laboratories. We
continue our work on developing
regulations for a national list of
reportable animal diseases.
Finally, the commenter asked for
clarity as to whether or not there are any
potential user fees for laboratory
approvals and inspections by APHIS
personnel.
User fees currently do apply with
respect to some inspections conducted
in connection with new or continuing
VerDate Sep<11>2014
15:58 Jan 23, 2020
Jkt 250001
approvals of laboratories, and those
existing fees are not affected by this
rule. Any new fees or adjustments to
existing fees would be the subject of a
separate regulatory action.
Revision to the Proposed Definition of
National Animal Health Laboratory
Network
In the proposed rule, we proposed to
define the term National Animal Health
Laboratory Network (NAHLN) as ‘‘a
nationally coordinated network and
partnership of Federal, State, and
university-associated animal health
laboratories that provide animal health
diagnostic testing, methods research and
development, and expertise for
education and extension to detect
biological threats to the nation’s animal
agriculture, thus protecting animal
health, public health, and the nation’s
food supply.’’ In this final rule, we are
revising this proposed definition to
indicate that the NAHLN is primarily
composed of Federal, State, and
university-associated animal health
laboratories. This is because, on a caseby-case basis, private laboratories may
be used in the NAHLN based on needed
capabilities.
Clarification Regarding Laboratory
Facility Approval
In the proposed rule, proposed
paragraph (b) of § 71.22 provided that
official testing would have to be
performed in laboratory facilities with
controlled conditions, instrumentation
appropriate for the testing being
conducted, and biosecurity measures
commensurate with the disease of
diagnostic concern, but neglected to
specify that each of these facility
requirements must be acceptable to
APHIS. In this final rule, we are
clarifying that the determinations that
the requirements have been met must be
made by APHIS, rather than the facility
itself.
Therefore, for the reasons given in the
proposed rule and in this document, we
are adopting the proposed rule as a final
rule, with the changes discussed in this
document. Executive Orders 12866 and
13771 and Regulatory Flexibility Act.
This rule has been determined to be
not significant for the purposes of
Executive Order 12866 and, therefore,
has not been reviewed by the Office of
Management and Budget. This rule is
not an Executive Order 13771 regulatory
action because it is not significant under
Executive Order 12866.
In accordance with the Regulatory
Flexibility Act, we have analyzed the
potential economic effects of this action
on small entities. The analysis is
summarized below. Copies of the full
PO 00000
Frm 00003
Fmt 4700
Sfmt 4700
4193
analysis are available by contacting the
person listed under FOR FURTHER
INFORMATION CONTACT or on the
Regulations.gov website (see footnote 1
above for a link to Regulations.gov).
This rule consolidates existing
diagnostic laboratory approval
authorities for certain animal diseases
into a single regulation and establishes
a framework that we will use to conduct
future diagnostic laboratory approvals.
The consolidated regulations will serve
to simplify regulatory oversight and
compliance, saving time and resources.
For both the laboratories and APHIS,
consolidating and standardizing the
process will create an easier-tounderstand and more user-friendly
approval process; improve efficiency in
obtaining approvals to conduct testing
for single or multiple diseases; reduce
the administrative burden associated
with obtaining and tracking laboratory
approvals; and simplify the steps
required to renew an existing approval.
There are over 400 APHIS-approved
laboratories. The laboratories range
widely in size, from one-person
practices to large, State-wide systems.
They are classified within the
Veterinary Services industry, for which
the Small Business Administration’s
small-entity standard is annual receipts
of not more than $7.5 million. For the
industry overall in 2012, there were
27,939 establishments that operated
throughout the year. Ninety-nine
percent (27,605 establishments) had
receipts of less than $5 million. Thus,
most of these entities are small.
Cost savings because of this rule
would be realized mainly by
approximately 50 larger laboratories due
to the multiple tests they perform. In
accordance with guidance on complying
with Executive Order 13771, the single
primary estimate of the yearly savings
that would be provided by this
proposed rule is $1.1 million, the midpoint estimate annualized in perpetuity
using a 7 percent discount rate.
This rule will lessen the
administrative burden for affected
laboratories, benefiting rather than
having any negative impact on them.
Under these circumstances, the
Administrator of the Animal and Plant
Health Inspection Service has
determined that this action will not
have a significant economic impact on
a substantial number of small entities.
Executive Order 12372
This program/activity is listed in the
Catalog of Federal Domestic Assistance
under No. 10.025 and is subject to
Executive Order 12372, which requires
intergovernmental consultation with
E:\FR\FM\24JAR1.SGM
24JAR1
4194
Federal Register / Vol. 85, No. 16 / Friday, January 24, 2020 / Rules and Regulations
9 CFR Part 93
State and local officials. (See 2 CFR
chapter IV.)
Executive Order 12988
This final rule has been reviewed
under Executive Order 12988, Civil
Justice Reform. This rule: (1) Preempts
all State and local laws and regulations
that are in conflict with this rule; (2) has
no retroactive effect; and (3) does not
require administrative proceedings
before parties may file suit in court
challenging this rule.
Congressional Review Act
Animal diseases, Imports, Livestock,
Poultry and poultry products, Reporting
and recordkeeping requirements.
Accordingly, we are amending 9 CFR
parts 71, 75, 80, and 93 as follows:
PART 71—GENERAL PROVISIONS
1. The authority citation for part 71
continues to read as follows:
■
Authority: 7 U.S.C. 8301–8317; 7 CFR
2.22, 2.80, and 371.4.
2. Section 71.1 is amended by adding
in alphabetical order definitions for
‘‘Approved laboratory’’, ‘‘National
Animal Health Laboratory Network
(NAHLN)’’, and ‘‘Official testing’’ to
read as follows:
■
Pursuant to the Congressional Review
Act (5 U.S.C. 801 et seq.), the Office of
Information and Regulatory Affairs
designated this rule as not a major rule,
as defined by 5 U.S.C. 804(2).
§ 71.1
Paperwork Reduction Act
In accordance with section 3507(d) of
the Paperwork Reduction Act of 1995
(44 U.S.C. 3501 et seq.), the reporting
and recordkeeping requirements
included in this final rule, which were
filed under 0579–0472, have been
submitted for approval to the Office of
Management and Budget (OMB). When
OMB notifies us of its decision, if
approval is denied, we will publish a
document in the Federal Register
providing notice of what action we plan
to take.
E-Government Act Compliance
The Animal and Plant Health
Inspection Service is committed to
compliance with the E-Government Act
to promote the use of the internet and
other information technologies, to
provide increased opportunities for
citizen access to Government
information and services, and for other
purposes. For information pertinent to
E-Government Act compliance related
to this rule, please contact Mr. Joseph
Moxey, APHIS’ Information Collection
Coordinator, at (301) 851–2483.
*
*
*
*
Approved laboratory. A laboratory
approved by the Administrator to
conduct official testing in accordance
with the regulations in § 71.22.
*
*
*
*
*
National Animal Health Laboratory
Network (NAHLN). The NAHLN is a
nationally coordinated network and
partnership of primarily Federal, State,
and university-associated animal health
laboratories that provide animal health
diagnostic testing, methods research and
development, and expertise for
education and extension to detect
biological threats to the nation’s animal
agriculture, thus protecting animal
health, public health, and the nation’s
food supply.
*
*
*
*
*
Official testing. Testing to determine
the disease status of animals for use in
State-Federal programs. Tests are
approved by the Administrator and
conducted by qualified analysts in an
approved laboratory.
*
*
*
*
*
§ 71.20
9 CFR Part 71
§ 71.21
Animal diseases, Livestock, Poultry
and poultry products, Quarantine,
Reporting and recordkeeping
requirements, Transportation.
lotter on DSKBCFDHB2PROD with RULES
Animal diseases, Horses, Quarantine,
Reporting and recordkeeping
requirements, Transportation.
9 CFR Part 80
Animal diseases, Livestock,
Transportation.
Jkt 250001
[Amended]
4. Section 71.21 is amended by
redesignating footnotes 8 and 9 as
footnotes 2 and 3, respectively.
■ 5. Section 71.22 is added to read as
follows:
■
9 CFR Part 75
15:58 Jan 23, 2020
[Amended]
3. Section 71.20 is amended by
redesignating footnote 7 as footnote 1.
■
List of Subjects
VerDate Sep<11>2014
Definitions.
*
§ 71.22 Approval of laboratories to
conduct official testing.
(a) Approvals. State, university, and
private laboratories must obtain APHIS
approval to conduct official testing for
those diseases covered by subchapters
B, C, and D of this chapter. Laboratories
PO 00000
Frm 00004
Fmt 4700
Sfmt 4700
seeking approval must meet the
requirements of this section.
(b) Facilities. Official testing must be
performed in laboratory facilities with
controlled conditions, instrumentation
appropriate for the testing being
conducted, and biosecurity measures
commensurate with the disease of
diagnostic concern; each of these facility
requirements must be acceptable to
APHIS. Approved laboratories must
agree to periodic, unannounced
inspection by APHIS personnel or other
APHIS-approved inspectors following
an APHIS-approved checklist.
(c) Quality system. Laboratories must
operate under a quality system
acceptable to APHIS. Components of
such systems include acceptable
documentation of procedures,
recordkeeping, training, reporting, and
corrective actions taken if standards and
procedures are not reached or
maintained. Adherence to certain
nationally or internationally established
quality systems recognized by APHIS
may be used to meet all or part of this
requirement.4 Quality system records
are subject to review during facility
inspections.
(d) Procedures. All official testing
must be conducted using APHISapproved assay methods,5 which may
include standard operating procedures
recognized by the National Veterinary
Services Laboratories (NVSL) or
National Animal Health Laboratory
Network, and/or diagnostic test kits
licensed by the USDA.
(e) Training. Official testing must be
conducted only by those individuals
who have completed APHIS-approved
training and have passed proficiency
tests administered by APHIS or its
official designee. These tests will be
administered annually or as necessary at
an interval stipulated by APHIS.
Supervisory oversight of official testing
must be performed by qualified
individuals, as determined by APHIS.
(f) Reporting. Approved laboratories
must report test results to APHIS and
State animal health officials using an
individualized (by disease) timeline
established by APHIS at the time of
laboratory approval.
(g) Applications for approval. (1)
Laboratories must use APHIS
application forms, including an
agreement to meet the obligations to
APHIS listed in this section, and submit
4 A list of established quality systems recognized
by APHIS is available on the internet at https://
www.nahln.org.
5 A list of approved assay methods is available on
the APHIS Laboratory Portal website at https://
www.nahln.org and at https://www.aphis.usda.gov/
aphis/ourfocus/animalhealth/animal-diseaseinformation.
E:\FR\FM\24JAR1.SGM
24JAR1
lotter on DSKBCFDHB2PROD with RULES
Federal Register / Vol. 85, No. 16 / Friday, January 24, 2020 / Rules and Regulations
completed forms to the NVSL Director.
The Director will make a preliminary
determination of the application’s
acceptability, based on initial review of
submitted materials and, when
appropriate, a needs assessment for
diagnostic capacity. These
determinations are made on an annual
basis, or as needed based on the number
of applications received.
(2) Applicants will be informed of the
preliminary determination. If positive,
applicants will then be able to request
a facility inspection and personnel
training, conducted in accordance with
this section. If negative, APHIS will
provide a rationale for the denial.
Denied applicants may appeal any
denials in accordance with the
regulations in paragraph (j) of this
section;
(3) When all requirements in this
section have been met, the NVSL
Director will issue a final approval.
Approvals are specific to those lab
personnel working at the inspected,
approved laboratory who have met the
eligibility and proficiency requirements.
Denied applicants may appeal any
denials in accordance with the
regulations in paragraph (j) of this
section.
(h) Maintenance of approved status.
(1) Previously approved laboratories
that wish to maintain their approved
status must reapply for APHIS approval
at least 1 month before their approval
term expires, or at least every 2 years,
whichever comes first. Laboratories
wishing to maintain approved status
must submit a renewal application form,
as supplied by APHIS, to the NVSL
Director.
(2) Approved laboratories must have
at least one individual with the required
training and unexpired proficiency
certification in their employ at all times.
(3) Approved laboratories must
perform the minimum number of tests
to maintain proficiency, as stipulated by
APHIS in the guidance documents
developed for individual test types.
(i) Probation, suspension, and
rescission of laboratory approval. (1)
Laboratories not conducting the
minimum number of tests as required by
paragraph (h)(3) of this section during a
single reporting period will be assigned
probationary status. A reporting period
is less than or equal to the time for
which the laboratory has been approved
to conduct testing by APHIS.
Laboratories on probation may continue
to conduct official testing. If the
minimum required number of tests are
not performed during two consecutive
reporting periods, the laboratory will
not be eligible for renewal of APHIS
approval. Exceptions to this
VerDate Sep<11>2014
15:58 Jan 23, 2020
Jkt 250001
requirement may be granted by the
NVSL Director upon request.
(2) Approval to conduct official
testing will be suspended in the event
that a laboratory experiences changes
that may impact its ability to provide
quality testing services. These changes
include: No longer employing an
individual approved to conduct official
testing, a move to different facilities, or
a natural disaster that impacts power or
water systems. Laboratories with
suspended status will not be approved
to conduct official testing. Laboratories
will be restored to approved status upon
training and/or testing new personnel,
successful inspection of new facilities,
and/or correction of noncompliance
issues. Reapproval will involve
resubmitting those sections of the
application materials required by the
NVSL Director.
(3) Approval may be rescinded at any
time, at the discretion of the NVSL
Director, if a laboratory fails to meet its
obligations to APHIS, as listed in the
agreement signed by the laboratory
during the application process. The
NVSL Director will issue a notice to the
laboratory, providing the justification
for the proposed removal. Laboratories
will have 30 days to respond in writing
to the concerns provided before the
NVSL Director finalizes the removal
decision.
(j) Appeals. Appeal of any denial,
probation, suspension, or rescission of
laboratory approval must be made in
writing to the APHIS Administrator or
the Administrator’s official designee
within 30 days of the laboratory’s
receipt of the NVSL Director’s decision.
Responses to these appeals will be
provided within 60 days of receipt by
APHIS.
(Approved by the Office of Management and
Budget under control number 0579–0472)
PART 75—COMMUNICABLE
DISEASES IN HORSES, ASSES,
PONIES, MULES, AND ZEBRAS
6. The authority citation for part 75
continues to read as follows:
■
Authority: 7 U.S.C. 8301–8317; 7 CFR
2.22, 2.80, and 371.4.
7. Section 75.4 is amended as follows:
a. By revising the section heading;
b. In paragraph (a), by removing the
definition of Official test and by revising
the definition of Reactor; and
■ c. By removing paragraphs (c) and (d).
The revisions read as follows:
■
■
■
test in accordance with the regulations
in § 71.22 of this subchapter and found
positive.
*
*
*
*
*
PART 80—JOHNE’S DISEASE IN
DOMESTIC ANIMALS
8. The authority citation for part 80
continues to read as follows:
■
Authority: 7 U.S.C. 8301–8317; 7 CFR
2.22, 2.80, and 371.4.
9. In § 80.1, the definition of ‘‘Official
Johne’s disease test’’ is revised to read
as follows:
■
§ 80.1
Definitions.
*
*
*
*
*
Official Johne’s disease test. An
organism detection test approved by the
Administrator and conducted in a
laboratory approved by the
Administrator.1
*
*
*
*
*
————————
1 The list of approved laboratories is
available on the internet at https://
www.nahln.org or upon request from the
Animal and Plant Health Inspection Service,
Veterinary Services, National Veterinary
Services Laboratories, P.O. Box 844, Ames,
IA 50010–0844.
PART 93—IMPORTATION OF CERTAIN
ANIMALS, BIRDS, FISH, AND
POULTRY, AND CERTAIN ANIMAL,
BIRD, AND POULTRY PRODUCTS;
REQUIREMENTS FOR MEANS OF
CONVEYANCE AND SHIPPING
CONTAINERS
10. The authority citation for part 93
continues to read as follows:
■
Authority: 7 U.S.C. 1622 and 8301–8317;
21 U.S.C. 136 and 136a; 31 U.S.C. 9701; 7
CFR 2.22, 2.80, and 371.4.
§ 93.301
11. Section 93.301 is amended as
follows:
■ a. In paragraphs (e)(2)(iii) and (e)(5)(i),
by removing the words ‘‘paragraph (i) of
this section’’ and adding the words
‘‘§ 71.22 of this chapter’’ in their place;
and
■ b. By removing and reserving
paragraph (i).
§ 93.303
12. Section 93.303 is amended by
redesignating footnote 12 as footnote 10.
(a) * * *
Reactor. Any horse, ass, mule, pony
or zebra which is subjected to an official
■
Fmt 4700
Sfmt 4700
[Amended]
■
§ 93.308
Frm 00005
[Amended]
■
§ 75.4 Interstate movement of equine
infectious anemia reactors.
PO 00000
4195
[Amended]
13. Section 93.308 is amended by
redesignating footnotes 13, 14, and 15 as
footnotes 11, 12, and 13, respectively.
E:\FR\FM\24JAR1.SGM
24JAR1
4196
Federal Register / Vol. 85, No. 16 / Friday, January 24, 2020 / Rules and Regulations
Done in Washington, DC, this 17th day of
January 2020.
Kevin Shea,
Administrator, Animal and Plant Health
Inspection Service.
[FR Doc. 2020–01114 Filed 1–23–20; 8:45 am]
BILLING CODE 3410–34–P
DEPARTMENT OF TRANSPORTATION
Examining the AD Docket
Federal Aviation Administration
You may examine the AD docket on
the internet at https://
www.regulations.gov by searching for
and locating Docket No. FAA–2019–
0581; or in person at Docket Operations
between 9 a.m. and 5 p.m., Monday
through Friday, except Federal holidays.
The AD docket contains this final rule,
the regulatory evaluation, any
comments received, and other
information. The address for Docket
Operations is U.S. Department of
Transportation, Docket Operations, M–
30, West Building Ground Floor, Room
W12–140, 1200 New Jersey Avenue SE,
Washington, DC 20590.
FOR FURTHER INFORMATION CONTACT:
Hector Hernandez, Aerospace Engineer,
Systems and Equipment Section, FAA,
Atlanta ACO Branch, 1701 Columbia
Avenue, College Park, GA 30337; phone:
404–474–5587; fax: 404–474–5606;
email: hector.hernandez@faa.gov.
SUPPLEMENTARY INFORMATION:
14 CFR Part 39
[Docket No. FAA–2019–0581; Product
Identifier 2019–NM–067–AD; Amendment
39–21019; AD 2019–25–20]
RIN 2120–AA64
Airworthiness Directives; Lockheed
Martin Corporation/Lockheed Martin
Aeronautics Company Airplanes
Federal Aviation
Administration (FAA), DOT.
ACTION: Final rule.
AGENCY:
The FAA is adopting a new
airworthiness directive (AD) for all
Lockheed Martin Corporation/Lockheed
Martin Aeronautics Company Model
382, 382B, 382E, 382F, and 382G
airplanes, type certificated in any
category; and Model C–130A, C–130B,
C–130BL, C–130E, C–130H, C–130H–30,
C–130J, C–130J–30, EC–130Q, HC–
130H, KC–130H, NC–130B, NC–130,
and WC–130H airplanes, type
certificated in the restricted or amateur
category. This AD was prompted by a
report indicating that two elevator
booster assemblies experienced
significant hydraulic fluid leaks, caused
by fatigue cracks in the actuator
cylinder. This AD requires an
inspection to determine the part number
of the elevator booster actuator,
repetitive ultrasonic inspections of the
actuator to detect cracking, and
replacement of cracked elevator booster
assemblies. The FAA is issuing this AD
to address the unsafe condition on these
products.
DATES: This AD is effective February 28,
2020.
The Director of the Federal Register
approved the incorporation by reference
of a certain publication listed in this AD
as of February 28, 2020.
ADDRESSES: For service information
identified in this final rule, contact
Lockheed Martin Corporation/Lockheed
Martin Aeronautics Company, Customer
Support Center, Dept. 3E1M, Zone 0591,
86 S Cobb Drive, Marietta, GA 30063;
telephone 770–494–9131; email
hercules.support@lmco.com; internet
https://www.Lockheedmartin.com. You
SUMMARY:
lotter on DSKBCFDHB2PROD with RULES
may view this service information at the
FAA, Transport Standards Branch, 2200
South 216th St., Des Moines, WA. For
information on the availability of this
material at the FAA, call 206–231–3195.
It is also available on the internet at
https://www.regulations.gov by
searching for and locating Docket No.
FAA–2019–0581.
VerDate Sep<11>2014
15:58 Jan 23, 2020
Jkt 250001
Discussion
The FAA issued a notice of proposed
rulemaking (NPRM) to amend 14 CFR
part 39 by adding an AD that would
apply to all Lockheed Martin
Corporation/Lockheed Martin
Aeronautics Company Model 382, 382B,
382E, 382F, and 382G airplanes, type
certificated in any category; and Model
C–130A, C–130B, C–130BL, C–130E, C–
130H, C–130H–30, C–130J, C–130J–30,
EC–130Q, HC–130H, KC–130H, NC–
130B, NC–130, and WC–130H airplanes,
type certificated in the restricted or
amateur category. The NPRM published
in the Federal Register on July 31, 2019
(84 FR 37165). The NPRM was
prompted by a report indicating that
two elevator booster assemblies
experienced significant hydraulic fluid
leaks, caused by fatigue cracks in the
actuator cylinder. The NPRM proposed
to require an inspection to determine
the part number of the elevator booster
actuator, repetitive ultrasonic
inspections of the actuator to detect
cracking, and replacement of cracked
elevator booster assemblies.
The FAA is issuing this AD to address
the possibility of a dual failure of the
left and right actuator cylinders in the
elevator booster assembly, which could
PO 00000
Frm 00006
Fmt 4700
Sfmt 4700
lead to a significant reduction in
controllability of the airplane.
Comments
The FAA gave the public the
opportunity to participate in developing
this final rule. The following presents
the comments received on the NPRM
and the FAA’s response to each
comment.
Lynden Air Cargo, LLC stated that it
concurred in concept and that the
proposed AD would enhance safety.
Request To Clarify Actions for Spare
Parts
Lynden Air Cargo, LLC requested
clarification whether the ultrasonic
inspection procedures in the proposed
AD can also be accomplished for offairplane spare elevator booster
actuators. The commenter noted that the
Accomplishment Instructions of
Lockheed Martin Aeronautics Company
Service Bulletin 382–27–51, Revision 1,
dated January 17, 2018, state to do the
inspection while the elevator booster
actuators are installed on the airplane.
The commenter asked that, if the
inspection cannot be done off-airplane,
alternative inspection procedures be
provided.
The FAA agrees to clarify. Lockheed
has issued Lockheed Martin
Aeronautics Company Service Bulletin
382–27–51, Revision 2, dated October 3,
2019. This service information has been
revised to clarify that the same
inspection procedures can be
accomplished with the elevator booster
actuators either on or off the airplane.
The FAA has revised this AD to refer to
the latest service information and to
provide credit for actions that were
accomplished using Lockheed Martin
Aeronautics Company Service Bulletin
382–27–51, Revision 1, dated January
17, 2018.
Request To Correct Exception Language
Lynden Air Cargo, LLC requested that
paragraph (h) of the proposed AD be
revised to refer to flight hours, rather
than flight cycles. The commenter noted
that all other references for compliance
time in the proposed AD and the service
information refer to flight hours.
The FAA agrees with the commenter’s
request. The NPRM inadvertently
referred to flight cycles rather than flight
hours in the location noted. Since
paragraph (h) of this AD is a compliance
time exception for certain airplanes,
revising the language will not adversely
affect safety, but will allow operators to
use this exception. This final rule has
been revised accordingly.
E:\FR\FM\24JAR1.SGM
24JAR1
Agencies
[Federal Register Volume 85, Number 16 (Friday, January 24, 2020)]
[Rules and Regulations]
[Pages 4192-4196]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-01114]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF AGRICULTURE
Animal and Plant Health Inspection Service
9 CFR Parts 71, 75, 80, and 93
[Docket No. APHIS-2016-0054]
RIN 0579-AE46
Approval of Laboratories To Conduct Official Testing;
Consolidation of Regulations
AGENCY: Animal and Plant Health Inspection Service, USDA.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: We are consolidating the regulations governing diagnostic
laboratory approval authorities for select animal diseases into a
single regulation and establishing a set of standard procedures that we
will use to conduct future diagnostic laboratory approvals. These
consolidated regulations will provide for consistent inspection
protocols, proficiency testing methods, quality system guidelines, and
definitions and will facilitate the approval of additional laboratories
in emergency situations. The consolidated regulations will serve to
simplify regulatory oversight and compliance.
DATES: February 24, 2020.
FOR FURTHER INFORMATION CONTACT: Dr. Randall L. Levings, Scientific
Advisor, Diagnostics and Biologics, VS, APHIS, 1920 Dayton Ave., Ames,
IA 50010-9602; (515) 337-7601.
SUPPLEMENTARY INFORMATION:
Background
The regulations in 9 CFR subchapters B, C, and D pertain to the
cooperative control and eradication of livestock or poultry diseases
(subchapter B), the interstate transportation of animals (including
poultry) and animal products (subchapter C), and the exportation and
importation of animals (including poultry) and animal products
(subchapter D).
In a proposed rule \1\ published in the Federal Register on May 30,
2019 (84 FR 25013-25018, Docket No. APHIS-2016-0054), we proposed to
consolidate the regulations governing diagnostic laboratory approval
authorities for animal diseases covered by 9 CFR subchapters B through
D into a single regulation and establish a set of standard procedures
that we would use to conduct future diagnostic laboratory
[[Page 4193]]
approvals. The consolidated regulations are intended to provide for
consistent inspection protocols, proficiency testing methods, quality
system guidelines, and definitions; facilitate the approval of
additional laboratories in emergency situations; and simplify
regulatory oversight and compliance.
---------------------------------------------------------------------------
\1\ To view the proposed rule, supporting documents, and the
comments we received, go to https://www.regulations.gov/docket?D=APHIS-2016-0054.
---------------------------------------------------------------------------
We solicited comments for 60 days ending on July 29, 2019. We
received six comments by that date, from private citizens and a State
animal health commission. All the commenters generally supported the
proposed rule. One commenter did raise a few questions, which are
discussed below.
As part of the proposed rule, we proposed to remove the specific
laboratory approval provisions found in our regulations regarding
equine infectious anemia, Johne's disease, and contagious equine
metritis. One commenter noted that the scope of the proposed
regulations could appear to be limited to those three diseases, but
stated they favored a more expansive interpretation that would include
all the diseases cited in 9 CFR subchapters B, C, and D.
The commenter's more expansive interpretation is correct. As stated
in proposed Sec. 71.22(a), State, university, and private laboratories
must obtain Animal and Plant Health Inspection Service (APHIS) approval
to conduct official testing for those diseases covered by subchapters
B, C, and D and must meet the requirements of Sec. 71.22 in order to
obtain and maintain that approval.
The same commenter stated that it should be clear that regulations
also apply to laboratories that test for other communicable diseases of
livestock or poultry that the Secretary may determine constitute an
emergency and pose a threat to animal health. In that vein, the
commenter also encouraged APHIS to continue to develop regulations for
a national list of reportable animal diseases.
As anticipated by the commenter, the regulations will serve as the
framework for the approval of laboratories that test for new or
emerging communicable diseases of livestock or poultry for which tests
are available should there be a need for those laboratories. We
continue our work on developing regulations for a national list of
reportable animal diseases.
Finally, the commenter asked for clarity as to whether or not there
are any potential user fees for laboratory approvals and inspections by
APHIS personnel.
User fees currently do apply with respect to some inspections
conducted in connection with new or continuing approvals of
laboratories, and those existing fees are not affected by this rule.
Any new fees or adjustments to existing fees would be the subject of a
separate regulatory action.
Revision to the Proposed Definition of National Animal Health
Laboratory Network
In the proposed rule, we proposed to define the term National
Animal Health Laboratory Network (NAHLN) as ``a nationally coordinated
network and partnership of Federal, State, and university-associated
animal health laboratories that provide animal health diagnostic
testing, methods research and development, and expertise for education
and extension to detect biological threats to the nation's animal
agriculture, thus protecting animal health, public health, and the
nation's food supply.'' In this final rule, we are revising this
proposed definition to indicate that the NAHLN is primarily composed of
Federal, State, and university-associated animal health laboratories.
This is because, on a case-by-case basis, private laboratories may be
used in the NAHLN based on needed capabilities.
Clarification Regarding Laboratory Facility Approval
In the proposed rule, proposed paragraph (b) of Sec. 71.22
provided that official testing would have to be performed in laboratory
facilities with controlled conditions, instrumentation appropriate for
the testing being conducted, and biosecurity measures commensurate with
the disease of diagnostic concern, but neglected to specify that each
of these facility requirements must be acceptable to APHIS. In this
final rule, we are clarifying that the determinations that the
requirements have been met must be made by APHIS, rather than the
facility itself.
Therefore, for the reasons given in the proposed rule and in this
document, we are adopting the proposed rule as a final rule, with the
changes discussed in this document. Executive Orders 12866 and 13771
and Regulatory Flexibility Act.
This rule has been determined to be not significant for the
purposes of Executive Order 12866 and, therefore, has not been reviewed
by the Office of Management and Budget. This rule is not an Executive
Order 13771 regulatory action because it is not significant under
Executive Order 12866.
In accordance with the Regulatory Flexibility Act, we have analyzed
the potential economic effects of this action on small entities. The
analysis is summarized below. Copies of the full analysis are available
by contacting the person listed under FOR FURTHER INFORMATION CONTACT
or on the Regulations.gov website (see footnote 1 above for a link to
Regulations.gov).
This rule consolidates existing diagnostic laboratory approval
authorities for certain animal diseases into a single regulation and
establishes a framework that we will use to conduct future diagnostic
laboratory approvals. The consolidated regulations will serve to
simplify regulatory oversight and compliance, saving time and
resources. For both the laboratories and APHIS, consolidating and
standardizing the process will create an easier-to-understand and more
user-friendly approval process; improve efficiency in obtaining
approvals to conduct testing for single or multiple diseases; reduce
the administrative burden associated with obtaining and tracking
laboratory approvals; and simplify the steps required to renew an
existing approval.
There are over 400 APHIS-approved laboratories. The laboratories
range widely in size, from one-person practices to large, State-wide
systems. They are classified within the Veterinary Services industry,
for which the Small Business Administration's small-entity standard is
annual receipts of not more than $7.5 million. For the industry overall
in 2012, there were 27,939 establishments that operated throughout the
year. Ninety-nine percent (27,605 establishments) had receipts of less
than $5 million. Thus, most of these entities are small.
Cost savings because of this rule would be realized mainly by
approximately 50 larger laboratories due to the multiple tests they
perform. In accordance with guidance on complying with Executive Order
13771, the single primary estimate of the yearly savings that would be
provided by this proposed rule is $1.1 million, the mid-point estimate
annualized in perpetuity using a 7 percent discount rate.
This rule will lessen the administrative burden for affected
laboratories, benefiting rather than having any negative impact on
them. Under these circumstances, the Administrator of the Animal and
Plant Health Inspection Service has determined that this action will
not have a significant economic impact on a substantial number of small
entities.
Executive Order 12372
This program/activity is listed in the Catalog of Federal Domestic
Assistance under No. 10.025 and is subject to Executive Order 12372,
which requires intergovernmental consultation with
[[Page 4194]]
State and local officials. (See 2 CFR chapter IV.)
Executive Order 12988
This final rule has been reviewed under Executive Order 12988,
Civil Justice Reform. This rule: (1) Preempts all State and local laws
and regulations that are in conflict with this rule; (2) has no
retroactive effect; and (3) does not require administrative proceedings
before parties may file suit in court challenging this rule.
Congressional Review Act
Pursuant to the Congressional Review Act (5 U.S.C. 801 et seq.),
the Office of Information and Regulatory Affairs designated this rule
as not a major rule, as defined by 5 U.S.C. 804(2).
Paperwork Reduction Act
In accordance with section 3507(d) of the Paperwork Reduction Act
of 1995 (44 U.S.C. 3501 et seq.), the reporting and recordkeeping
requirements included in this final rule, which were filed under 0579-
0472, have been submitted for approval to the Office of Management and
Budget (OMB). When OMB notifies us of its decision, if approval is
denied, we will publish a document in the Federal Register providing
notice of what action we plan to take.
E-Government Act Compliance
The Animal and Plant Health Inspection Service is committed to
compliance with the E-Government Act to promote the use of the internet
and other information technologies, to provide increased opportunities
for citizen access to Government information and services, and for
other purposes. For information pertinent to E-Government Act
compliance related to this rule, please contact Mr. Joseph Moxey,
APHIS' Information Collection Coordinator, at (301) 851-2483.
List of Subjects
9 CFR Part 71
Animal diseases, Livestock, Poultry and poultry products,
Quarantine, Reporting and recordkeeping requirements, Transportation.
9 CFR Part 75
Animal diseases, Horses, Quarantine, Reporting and recordkeeping
requirements, Transportation.
9 CFR Part 80
Animal diseases, Livestock, Transportation.
9 CFR Part 93
Animal diseases, Imports, Livestock, Poultry and poultry products,
Reporting and recordkeeping requirements.
Accordingly, we are amending 9 CFR parts 71, 75, 80, and 93 as
follows:
PART 71--GENERAL PROVISIONS
0
1. The authority citation for part 71 continues to read as follows:
Authority: 7 U.S.C. 8301-8317; 7 CFR 2.22, 2.80, and 371.4.
0
2. Section 71.1 is amended by adding in alphabetical order definitions
for ``Approved laboratory'', ``National Animal Health Laboratory
Network (NAHLN)'', and ``Official testing'' to read as follows:
Sec. 71.1 Definitions.
* * * * *
Approved laboratory. A laboratory approved by the Administrator to
conduct official testing in accordance with the regulations in Sec.
71.22.
* * * * *
National Animal Health Laboratory Network (NAHLN). The NAHLN is a
nationally coordinated network and partnership of primarily Federal,
State, and university-associated animal health laboratories that
provide animal health diagnostic testing, methods research and
development, and expertise for education and extension to detect
biological threats to the nation's animal agriculture, thus protecting
animal health, public health, and the nation's food supply.
* * * * *
Official testing. Testing to determine the disease status of
animals for use in State-Federal programs. Tests are approved by the
Administrator and conducted by qualified analysts in an approved
laboratory.
* * * * *
Sec. 71.20 [Amended]
0
3. Section 71.20 is amended by redesignating footnote 7 as footnote 1.
Sec. 71.21 [Amended]
0
4. Section 71.21 is amended by redesignating footnotes 8 and 9 as
footnotes 2 and 3, respectively.
0
5. Section 71.22 is added to read as follows:
Sec. 71.22 Approval of laboratories to conduct official testing.
(a) Approvals. State, university, and private laboratories must
obtain APHIS approval to conduct official testing for those diseases
covered by subchapters B, C, and D of this chapter. Laboratories
seeking approval must meet the requirements of this section.
(b) Facilities. Official testing must be performed in laboratory
facilities with controlled conditions, instrumentation appropriate for
the testing being conducted, and biosecurity measures commensurate with
the disease of diagnostic concern; each of these facility requirements
must be acceptable to APHIS. Approved laboratories must agree to
periodic, unannounced inspection by APHIS personnel or other APHIS-
approved inspectors following an APHIS-approved checklist.
(c) Quality system. Laboratories must operate under a quality
system acceptable to APHIS. Components of such systems include
acceptable documentation of procedures, recordkeeping, training,
reporting, and corrective actions taken if standards and procedures are
not reached or maintained. Adherence to certain nationally or
internationally established quality systems recognized by APHIS may be
used to meet all or part of this requirement.\4\ Quality system records
are subject to review during facility inspections.
---------------------------------------------------------------------------
\4\ A list of established quality systems recognized by APHIS is
available on the internet at https://www.nahln.org.
---------------------------------------------------------------------------
(d) Procedures. All official testing must be conducted using APHIS-
approved assay methods,\5\ which may include standard operating
procedures recognized by the National Veterinary Services Laboratories
(NVSL) or National Animal Health Laboratory Network, and/or diagnostic
test kits licensed by the USDA.
---------------------------------------------------------------------------
\5\ A list of approved assay methods is available on the APHIS
Laboratory Portal website at https://www.nahln.org and at https://www.aphis.usda.gov/aphis/ourfocus/animalhealth/animal-disease-information.
---------------------------------------------------------------------------
(e) Training. Official testing must be conducted only by those
individuals who have completed APHIS-approved training and have passed
proficiency tests administered by APHIS or its official designee. These
tests will be administered annually or as necessary at an interval
stipulated by APHIS. Supervisory oversight of official testing must be
performed by qualified individuals, as determined by APHIS.
(f) Reporting. Approved laboratories must report test results to
APHIS and State animal health officials using an individualized (by
disease) timeline established by APHIS at the time of laboratory
approval.
(g) Applications for approval. (1) Laboratories must use APHIS
application forms, including an agreement to meet the obligations to
APHIS listed in this section, and submit
[[Page 4195]]
completed forms to the NVSL Director. The Director will make a
preliminary determination of the application's acceptability, based on
initial review of submitted materials and, when appropriate, a needs
assessment for diagnostic capacity. These determinations are made on an
annual basis, or as needed based on the number of applications
received.
(2) Applicants will be informed of the preliminary determination.
If positive, applicants will then be able to request a facility
inspection and personnel training, conducted in accordance with this
section. If negative, APHIS will provide a rationale for the denial.
Denied applicants may appeal any denials in accordance with the
regulations in paragraph (j) of this section;
(3) When all requirements in this section have been met, the NVSL
Director will issue a final approval. Approvals are specific to those
lab personnel working at the inspected, approved laboratory who have
met the eligibility and proficiency requirements. Denied applicants may
appeal any denials in accordance with the regulations in paragraph (j)
of this section.
(h) Maintenance of approved status. (1) Previously approved
laboratories that wish to maintain their approved status must reapply
for APHIS approval at least 1 month before their approval term expires,
or at least every 2 years, whichever comes first. Laboratories wishing
to maintain approved status must submit a renewal application form, as
supplied by APHIS, to the NVSL Director.
(2) Approved laboratories must have at least one individual with
the required training and unexpired proficiency certification in their
employ at all times.
(3) Approved laboratories must perform the minimum number of tests
to maintain proficiency, as stipulated by APHIS in the guidance
documents developed for individual test types.
(i) Probation, suspension, and rescission of laboratory approval.
(1) Laboratories not conducting the minimum number of tests as required
by paragraph (h)(3) of this section during a single reporting period
will be assigned probationary status. A reporting period is less than
or equal to the time for which the laboratory has been approved to
conduct testing by APHIS. Laboratories on probation may continue to
conduct official testing. If the minimum required number of tests are
not performed during two consecutive reporting periods, the laboratory
will not be eligible for renewal of APHIS approval. Exceptions to this
requirement may be granted by the NVSL Director upon request.
(2) Approval to conduct official testing will be suspended in the
event that a laboratory experiences changes that may impact its ability
to provide quality testing services. These changes include: No longer
employing an individual approved to conduct official testing, a move to
different facilities, or a natural disaster that impacts power or water
systems. Laboratories with suspended status will not be approved to
conduct official testing. Laboratories will be restored to approved
status upon training and/or testing new personnel, successful
inspection of new facilities, and/or correction of noncompliance
issues. Reapproval will involve resubmitting those sections of the
application materials required by the NVSL Director.
(3) Approval may be rescinded at any time, at the discretion of the
NVSL Director, if a laboratory fails to meet its obligations to APHIS,
as listed in the agreement signed by the laboratory during the
application process. The NVSL Director will issue a notice to the
laboratory, providing the justification for the proposed removal.
Laboratories will have 30 days to respond in writing to the concerns
provided before the NVSL Director finalizes the removal decision.
(j) Appeals. Appeal of any denial, probation, suspension, or
rescission of laboratory approval must be made in writing to the APHIS
Administrator or the Administrator's official designee within 30 days
of the laboratory's receipt of the NVSL Director's decision. Responses
to these appeals will be provided within 60 days of receipt by APHIS.
(Approved by the Office of Management and Budget under control
number 0579-0472)
PART 75--COMMUNICABLE DISEASES IN HORSES, ASSES, PONIES, MULES, AND
ZEBRAS
0
6. The authority citation for part 75 continues to read as follows:
Authority: 7 U.S.C. 8301-8317; 7 CFR 2.22, 2.80, and 371.4.
0
7. Section 75.4 is amended as follows:
0
a. By revising the section heading;
0
b. In paragraph (a), by removing the definition of Official test and by
revising the definition of Reactor; and
0
c. By removing paragraphs (c) and (d).
The revisions read as follows:
Sec. 75.4 Interstate movement of equine infectious anemia reactors.
(a) * * *
Reactor. Any horse, ass, mule, pony or zebra which is subjected to
an official test in accordance with the regulations in Sec. 71.22 of
this subchapter and found positive.
* * * * *
PART 80--JOHNE'S DISEASE IN DOMESTIC ANIMALS
0
8. The authority citation for part 80 continues to read as follows:
Authority: 7 U.S.C. 8301-8317; 7 CFR 2.22, 2.80, and 371.4.
0
9. In Sec. 80.1, the definition of ``Official Johne's disease test''
is revised to read as follows:
Sec. 80.1 Definitions.
* * * * *
Official Johne's disease test. An organism detection test approved
by the Administrator and conducted in a laboratory approved by the
Administrator.\1\
* * * * *
----------------
\1\ The list of approved laboratories is available on the
internet at https://www.nahln.org or upon request from the Animal
and Plant Health Inspection Service, Veterinary Services, National
Veterinary Services Laboratories, P.O. Box 844, Ames, IA 50010-0844.
PART 93--IMPORTATION OF CERTAIN ANIMALS, BIRDS, FISH, AND POULTRY,
AND CERTAIN ANIMAL, BIRD, AND POULTRY PRODUCTS; REQUIREMENTS FOR
MEANS OF CONVEYANCE AND SHIPPING CONTAINERS
0
10. The authority citation for part 93 continues to read as follows:
Authority: 7 U.S.C. 1622 and 8301-8317; 21 U.S.C. 136 and 136a;
31 U.S.C. 9701; 7 CFR 2.22, 2.80, and 371.4.
Sec. 93.301 [Amended]
0
11. Section 93.301 is amended as follows:
0
a. In paragraphs (e)(2)(iii) and (e)(5)(i), by removing the words
``paragraph (i) of this section'' and adding the words ``Sec. 71.22 of
this chapter'' in their place; and
0
b. By removing and reserving paragraph (i).
Sec. 93.303 [Amended]
0
12. Section 93.303 is amended by redesignating footnote 12 as footnote
10.
Sec. 93.308 [Amended]
0
13. Section 93.308 is amended by redesignating footnotes 13, 14, and 15
as footnotes 11, 12, and 13, respectively.
[[Page 4196]]
Done in Washington, DC, this 17th day of January 2020.
Kevin Shea,
Administrator, Animal and Plant Health Inspection Service.
[FR Doc. 2020-01114 Filed 1-23-20; 8:45 am]
BILLING CODE 3410-34-P